期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 17, 期 10, 页码 3276-3280出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2021.1945901
关键词
Clinical trial; COVID-19; vaccine; lanscape
资金
- Chinese Academy of Medical Sciences' Initiative for Innovative Medicine [2020-I2M-2-007]
This review depicts the current landscape of global COVID-19 vaccine research and development, summarizing key characteristics and available evidence on authorized vaccines for emergency use. It aims to provide insights for stakeholders to improve coordination in responding to the COVID-19 outbreak.
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected billions of lives globally, and the world hopes to end this epidemic by effective vaccination. In this review, we depict the latest panorama of global COVID-19 vaccine research and development based on different technology platforms, and summarize key characteristics and available evidence on vaccines authorized for emergency use, in order to provide insights into improve coordination in the COVID-19 outbreak response for related stakeholders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据